Stay updated on LEGEND Clinical Trial: Lanifibranor and EmpaGliflozin in NASH with T2DM

Sign up to get notified when there's something new on the LEGEND Clinical Trial: Lanifibranor and EmpaGliflozin in NASH with T2DM page.
Latest website image capture
Clouds background image

Latest updates to the LEGEND Clinical Trial: Lanifibranor and EmpaGliflozin in NASH with T2DM page

  1. Check
    yesterday
    Change Detected
    Summary
    The most recent version adds sections for Outcome Measures (Results), Document Section, Outcome Measures, and Study Status, and notes that the Quality Control Review Has Not Concluded. This indicates the latest submission includes results-related content and shows a pending QC status for the record.
    Difference
    0.6%
    Check dated 2026-09-06T12:14:31.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    A new version entry (22) dated 2026-08-24 is added to the study record history, introducing multiple expanded sections such as Returned, Quality Control Review Has Not Concluded, Limitations and Caveats, and Outcome Measures (Results), Baseline Characteristics, Participant Flow, and Study Design. The update also notes Revision: v3.6.6 and removes Revision: v3.6.5, reflecting an update to the record's documentation and structure.
    Difference
    1%
    Check dated 2026-08-30T06:20:53.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    A new revision entry v3.6.5 is added to the study's version history, and the previous revision v3.6.4 is removed from the visible history to update the audit trail.
    Difference
    0.1%
    Check dated 2026-08-08T23:21:45.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The latest version shows major study-data sections and QC status, along with the Returned date. This reflects the addition of structured data areas in the record history.
    Difference
    1%
    Check dated 2026-08-01T20:05:03.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    The study history shows a new page revision label: v3.6.4, replacing the previous v3.6.3. This indicates an updated page build of the record history rather than changes to the study data.
    Difference
    0.1%
    Check dated 2026-07-25T17:03:53.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    The latest version entry shows Results Submitted and Revision: v3.6.3. It replaces the previous No Results Posted and Revision: v3.6.2.
    Difference
    0.2%
    Check dated 2026-07-04T04:54:09.000Z thumbnail image

Stay in the know with updates to LEGEND Clinical Trial: Lanifibranor and EmpaGliflozin in NASH with T2DM

Enter your email address, and we'll notify you when there's something new on the LEGEND Clinical Trial: Lanifibranor and EmpaGliflozin in NASH with T2DM page.